Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmaco-EEG in psychiatry.

Armida Mucci1, Umberto Volpe, Eleonora Merlotti

  • 1Department of Psychiatry, University of Naples SUN, Naples, Italy. armucci@tin.it

Clinical EEG and Neuroscience
|June 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negative symptoms in schizophrenia: Methodological challenges and emerging solutions for outcome measurement.

Neuroscience applied·2026
Same author

Negative symptoms of schizophrenia demonstrate measurement bias across sociodemographic variables.

Schizophrenia research·2026
Same author

Understanding the burden of cognitive impairment associated with schizophrenia: Results from the international LUCIA study.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials.

Molecular psychiatry·2026
Same author

Symptom Network Dynamics during Antipsychotic Treatment in First-Episode Psychosis.

Schizophrenia bulletin·2026
Same author

Persistent negative symptoms in the EULAST cohort: impact on functional outcome.

Schizophrenia (Heidelberg, Germany)·2026
Same journal

Isolated Paroxysmal Right Upward Eye Deviation as the Sole Semiology of Childhood Occipital Epilepsy: An Electroclinical Case Report.

Clinical EEG and neuroscience·2026
Same journal

Hyperkinetic Seizures in Insular and Insulo-Opercular Seizure Onset: A Systematic Review.

Clinical EEG and neuroscience·2026
Same journal

Aperiodic Correction of Posterior Theta/Alpha Ratio Reduces Arousal-State Dependency in Routine EEG-Based Dementia Screening.

Clinical EEG and neuroscience·2026
Same journal

QEEG Guided Neurofeedback to Enhance Intellectual Functioning in Children with Intellectual Disability.

Clinical EEG and neuroscience·2026
Same journal

Brain Activity Changes Induced by Transcranial Direct Current Stimulation in Post-Stroke Motor Recovery: A Narrative Review.

Clinical EEG and neuroscience·2026
Same journal

EEG Profile Associated with the Developmental Outcomes of Preschool Children Born Very Preterm.

Clinical EEG and neuroscience·2026
See all related articles

Pharmaco-electroencephalography (EEG) shows promise for monitoring drug toxicity and predicting treatment response in psychiatry. However, despite consistent findings, these applications have not yet been integrated into clinical practice due to methodological limitations.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Pharmaco-electroencephalography (EEG) has historically aided in psychotropic drug classification and discovery.
  • Current clinical applications of pharmaco-EEG in psychiatry are limited, despite its potential.

Purpose of the Study:

  • To review attempts at integrating pharmaco-EEG into psychiatric clinical routine for drug toxicity monitoring and treatment response prediction.
  • To assess the impact of these applications on current clinical practice.

Main Methods:

  • Review of existing pharmaco-EEG studies focusing on central nervous system toxicity and clinical response prediction for various psychotropic drug classes.
  • Analysis of methodological limitations and clinical impact of reviewed studies.

Related Experiment Videos

Main Results:

  • Pharmaco-EEG monitoring for antipsychotic and lithium toxicity showed potential but did not become routine clinical practice.
  • EEG studies on recreational drug toxicity faced limitations and failed to yield reliable clinical indices.
  • Quantitative EEG (QEEG) studies on predicting response to first-generation antipsychotics yielded consistent findings but lacked clinical impact.
  • Limited and inconsistent reports exist for other psychotropic drug classes regarding response prediction.

Conclusions:

  • Pharmaco-EEG possesses significant potential for clinical applications in psychiatry, particularly in toxicity monitoring and treatment response prediction.
  • Methodological limitations and a lack of large-scale studies have prevented the adoption of pharmaco-EEG into routine clinical practice.
  • Future efforts should focus on refining theories, improving methods, and conducting large-scale studies to realize the clinical potential of pharmaco-EEG.